While TS treatment could significantly increase the levels of synaptophysin (Figures 10A,B) and PSD-95 (Figures 10A,C), suggesting that TS treatment could effectively prevent synaptic loss in the brain of AD mice. This evidence concerns the gene SYP and Alzheimer disease.